Defence Therapeutics Inc. | WebDisclosure

Basculer en Français

9480	Companies
185523	Keywords
117911	Articles
99370	Press releases

Headlines Articles Press releases Defence Therapeutics Inc.

Home
Companies
Defence Therapeutics Inc.

PRESS RELEASE

published on 06/17/2024 at 08:00, 1 year 5 months ago

DEFENCE’S CHIEF SCIENTIFIC OFFICER DR. MOUTIH RAFEI DISCUSSES THE ACCUM PLATFORM FOR CANCER TREATMENTS ON MONEY TALK RADIO WITH ELLIS MARTIN
Defence Therapeutics Inc.'s Chief Scientific Officer Dr. Moutih Rafei discusses the ACCUM platform for cancer treatments on Money Talk Radio with Ellis Martin

Defence Therapeutics Inc. Cancer Treatments ACCUM Platform Dr. Moutih Rafei Money Talk Radio
BRIEF

published on 06/10/2024 at 08:05, 1 year 5 months ago

Defence Therapeutics participera au congrès annuel 2024 du SNMMI à Toronto

Thérapeutique De Défense SNMMI AccuTRIC™ Médecine Nucléaire Imagerie Moléculaire
BRIEF

published on 06/10/2024 at 08:05, 1 year 5 months ago

Defence Therapeutics to Attend 2024 SNMMI Annual Meeting in Toronto

Defence Therapeutics Nuclear Medicine SNMMI AccuTRIC™ Molecular Imaging
PRESS RELEASE

published on 06/10/2024 at 08:00, 1 year 5 months ago

DEFENCE TO PARTICIPATE TO 2024 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ANNUAL MEETING IN TORONTO ON JUNE 11, 2024
Defence Therapeutics Inc. to participate in the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto on June 11, 2024, presenting their novel Radio-Immuno-Conjugate (RIC) for cancer treatment

Cancer Treatment Defence Therapeutics Inc. Molecular Imaging Society Of Nuclear Medicine Radio-Immuno-Conjugate
BRIEF

published on 06/06/2024 at 08:05, 1 year 5 months ago

L'étude AccuTOX de Defense Therapeutics publiée dans le Journal of Translational Medicine

Immunothérapie Essais Cliniques Thérapeutique De Défense AccuTOX Anti-cancer
BRIEF

published on 06/06/2024 at 08:05, 1 year 5 months ago

Defence Therapeutics' AccuTOX Study Published in Journal of Translational Medicine

Clinical Trials Immunotherapy Defence Therapeutics AccuTOX Anti-cancer
PRESS RELEASE

published on 06/06/2024 at 08:00, 1 year 5 months ago

DEFENCE’S ACCUTOX PUBLISHED IN THE PRESTIGIOUS JOURNAL OF TRANSLATIONAL MEDICINE ITS PEER STUDY WITH PRECLINICAL DATA ON ACCUTOX AS AN ANTI-CANCER MOLECULE
Defence Therapeutics Inc.'s AccuTOX published in the prestigious Journal of Translational Medicine along with preclinical data on AccuTOX as an anti-cancer molecule. Study highlights AccuTOX's superior therapeutic properties and versatility for different cancer treatments

Preclinical Data Defence Therapeutics Inc. AccuTOX Journal Of Translational Medicine Anti-cancer Molecule
BRIEF

published on 05/14/2024 at 08:05, 1 year 6 months ago

Defence Therapeutics étend son portefeuille de brevets à l'échelle mondiale

Thérapeutique De Défense Délivrance De Brevet Innovation Dans Les Soins De Santé Vaccin Immuno-oncologique Système De Délivrance De Médicaments
BRIEF

published on 05/14/2024 at 08:05, 1 year 6 months ago

Defence Therapeutics Expands Patent Portfolio Globally

Defence Therapeutics Patent Issuance Drug Delivery System Innovation In Healthcare Immune-Oncology Vaccine
PRESS RELEASE

published on 05/14/2024 at 08:00, 1 year 6 months ago

DEFENCE THERAPEUTICS STRENGTHENS AND EXPANDS GLOBAL PATENT PROTECTION ON KEY TECHNOLOGIES
Defence Therapeutics strengthens and expands global patent protection on key technologies, including vaccine enhancer platform and ADC platform technology. The new patents and allowances showcase the company's commitment to innovation in biopharmaceuticals

Biopharmaceuticals Defence Therapeutics Patent Protection Vaccine Enhancer ADC Platform Technology

Accesswire

Published on 12/05/2025 at 18:20, 17 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 37 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 1 hour 22 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 1 hour 37 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 2 hours 37 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:26, 11 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 22 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 46 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 51 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:00, 1 hour 37 minutes ago

EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance

Les Echos

Published on 12/05/2025 at 17:18, 1 hour 19 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 1 hour 19 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 3 hours 27 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 3 hours 27 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 4 hours 39 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE